Skip to main content
SpringerLink
Log in

Treatment of Helicobacter pylori-Positive Lesions: 13C-Urea Breath Test Monitoring and Morphology

  • Conference paper
Helicobacter pylori and Gastroduodenal Pathology

  • 99 Accesses

Abstract

Helicobacter pylori (HP) is now generally accepted as a major pathogenetic factor in antral gastritis and ulcer disease [1–5]. The evidence which links HP infection to peptic ulceration is strongest in duodenal ulcer (DU) and less powerful in gastric ulcer (GU). As far as DU is concerned, however, eradication of infection markedly alters the natural history of the disease [6, 7]. Therefore, very recently the Sidney Working Party on Gastroenterology recommended HP eradication in patients suffering from DU [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Marshall BJ, Warren JR, Blincow ED, Phillips M, Goodwin CS, Murray R, Blackbourn SJ, Waters TE, Sanderson CR (1988) Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet II: 1437–1441

    Article  Google Scholar 

  2. Goodwin CS (1988) Duodenal ulcer, Campylobacter pylori, and the “leaking roof” concept. Lancet II: 1467–1469

    Article  Google Scholar 

  3. Graham DY (1989) Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615–625

    PubMed  CAS  Google Scholar 

  4. Tytgat GNJ, Axon ATR, Dixon MF, Graham DY, Lee A, Marshall BJ (1990) Helicobacter pylori: causal agent in peptic ulcer disease? In : Falk H (ed) Helicobacter pylori. Literature Review no 9, 3rd quarter. Falk, Freiburg, pp 360–369

    Google Scholar 

  5. Drumm B (1990) Helicobacter pylori. Arch Dis Child 65:1278–1282

    Article  PubMed  CAS  Google Scholar 

  6. Rauws EAJ, Tytgat GNJ (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1:1233–1235

    Article  Google Scholar 

  7. George LL, Borody TJ, Andrews P, Devine M, Moore-Jones D, Walton M, Brandi S (1990) Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 153:145–149

    PubMed  CAS  Google Scholar 

  8. Graham DY, Klein PD, Evans DJ, Evans DG, Alpert LC, Opekun AR, Boutton TW (1987) Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1:1174–1178

    Article  PubMed  CAS  Google Scholar 

  9. Eggers RH, Kulp A, Tegeler R, Lüdtke FE, Lepsien G, Meyer B, Bauer FE (1990) A methodological analysis of the 13C-urea breath test for detection of Helicobacter pylori infections: high sensitivity and specificity within 30 min using 75 mg of 13C-urea. Eur J Gastroenterol Hepatol 2:437–444

    Google Scholar 

  10. Colin-Jones DG (1988) Management of dyspepsia: report of a working party. Lancet 1:576–579

    Google Scholar 

  11. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ (1988) Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 94:33–40

    PubMed  CAS  Google Scholar 

  12. Cooreman M, Hengels KJ, Krausgrill P, Strohmeyer G (1990) 13 C-Harnstoff-Atemtest als nicht invasive Methode zum Nachweis von Helicobacter (Campylobacter) pylori. Dtsch Med Wochenschr 115:367–371

    Article  PubMed  CAS  Google Scholar 

  13. Dill S, Payne-James JJ, Misiewicz JJ, Grimble GK, McSwiggan D, Pathak K, Wood AJ, Scrimgeour CM, Rennie MJ (1990) Evaluation of 13C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non-ulcer dyspepsia. Gut 31:1237–1241

    Article  PubMed  CAS  Google Scholar 

  14. Mannes GA, Bayerdörffer E, Höchter W, Weingart J, Heldwein W. Müller-Lissner S, Oertel H, Blendinger Ch, Kuntzen O, Bornschein W, Malfertheiner P, Wilkening J, Ruckdeschel G, Pfaller P, van Wulffen H, Köpcke W, Stolte M (1990) Relapse rate of H. pylori (HP) positive duodenal ulcers (DU) following antibacterial therapy. In: Abstracts of the world congress of gastroenterology, Sydney, Australia. Medicine Group, Abingdon, P 955

    Google Scholar 

  15. Goodwin CS, Marshall BJ, Warren JR, Blackbourn S, Blincow ED (1987) Clearance of Campylobacter pyloridis and reduced duodenal ulcer relapse with bismuth and tinidazole compared to cimetidine. In: Kaijser B, Falsen E (eds) Campylobacter, vol 4. University of Göteborg, Göteborg, pp 368–369

    Google Scholar 

  16. Lambert JR, Borromeo M, Korman MG, Hansky J, Eaves ER (1987) Effect of colloidal bismuth (De-Nol) on healing and relapse of duodenal ulcers-role of Campylobacter pyloridis. In: Kaijser B, Falsen E (eds) Campylobacter, vol 4. University of Göteborg, Göteborg, p 383

    Google Scholar 

  17. Börsch G, Mai U, Müller KM (1988) Monotherapy or polychemotherapy in the treatment of Campylobacter pylori-related gastroduodenal disease. Scand J Gastroenterol 23 [Suppl 142]: 101–106

    Article  Google Scholar 

  18. Bayerdörffer E, Ottenjann R (1988) The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol 23 [Suppl 142]: 93–100

    Article  Google Scholar 

  19. Glupczynski Y, Burette A, Labbe M, Deprez C, De Reuck M, Deltenre M (1988) Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol 83:365–372

    PubMed  CAS  Google Scholar 

  20. Glupczynski Y, Burette A, Nyst JF (1988) Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens. Acta Gastroenterol Belg 5:329–337

    Google Scholar 

  21. Lamouliatte H, de Mascarel A, Megraud FM, Barberis C, Bernard PH, Cayla R, Quinton A (1990) Omeprazole improves amoxycillin therapy directed towards Helicobacter pylori associated chronic gastritis. Gastroenterology 98 : A75

    Google Scholar 

  22. Börsch G (1991) Treatment regimens to eradicate Helicobacter pylori. In: Menge H, Gregor M, Tytgat GNJ, Marshall BJ, McNulty CAM (eds) Helicobacter pylori 1990. Springer, Berlin Heidelberg New York, pp 209–215

    Chapter  Google Scholar 

  23. Hirschl AM, Hentschel E, Schütze K, Nemec H, Pötzi R, Gangl A, Weiss W, Pletschette M, Stanek G, Rotter ML (1988) The efficacy of antimicrobial treatment in Campylobacter pylori associated gastritis and duodenal ulcer. Scand J Gastroenterol 23 [Suppl 142]: 76–81

    Article  Google Scholar 

  24. O’Morain C (1990) How to eradicate Helicobacter pylori and prevent reinfection. In: Malfertheiner P, Ditschuneit H (eds) Helicobacter pylori, gastritis and peptic ulcer. Springer, Berlin Heidelberg New York, pp 388–394

    Google Scholar 

  25. O’Riordan T, Mathai E, Tobin E, McKenna D, Keane C, Swenney E, O’Morain C (1990) Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 31:999–1002

    Article  PubMed  Google Scholar 

  26. Graham DY, Lew GM, Opekun AR, Klein PD, Evans DG, Evans DJ Jr, Alpert LC, Michaletz PA (1990) Controlled evaluation of the effectiveness of triple therapy in eradication of Helicobacter pylori infection. Gastroenterology 98 : A 452

    Google Scholar 

  27. Lambert JR, Lin SK, Borromeo M, Nicholson L, Korman MG, Hansky J, Monash (1990) Eradication of Helicobacter pylori with colloidal bismuth subcitrate/antibiotic combinations. Gastroenterology 98 : A74

    Google Scholar 

  28. McNulty CAM, Eyre-Brook I A, Uff JS, Dent JC, Wilkinson SP (1989) Triple therapy is not always 95% effective. 5th international workshop on Campylobacter infections, Puerto Vallarata, Mexico

    Google Scholar 

  29. Borody TJ, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, Brandi S, Borody EG, George LL (1989) Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 151:431–435

    PubMed  CAS  Google Scholar 

  30. Tytgat GNJ, Rauws EAJ, De Koster E (1988) Campylobacter pylori. Scand J Gastroenterol Suppl 155:68–79

    Article  PubMed  CAS  Google Scholar 

  31. Eberhardt R, Kasper G (1990) Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer. Rev Infect Dis 12:115–119

    Article  Google Scholar 

  32. Goodwin CS, Armstrong JA, Wilson DH (1988) Differences between in vitro and in vivo sensibility of Campylobacter pylori to antibacterials. In: Menge H, Gregor M, Tytgat GNJ, Marshall BJ (eds) Campylobacter pylori. Springer, Berlin Heidelberg New York, pp 29–36

    Chapter  Google Scholar 

  33. Hollingsworth JA, Goldie J, Silette LY, Richardson H, Hunt RH (1987) Gastric secretion of antibiotics used for Campylobacter pyloridis. Gut 28: A 1409

    Google Scholar 

  34. Glupczynski Y, Burette A, De Koster E, Nyst JF, Deltenre M, Cadranel S, Bourdeaux L, De Vos D (1990) Metronidazole resistance in Helicobacter pylori. Lancet 1:976–977

    Article  Google Scholar 

  35. Stolte M, Eidt S, Ohnsmann A (1990) Differences in Helicobacter pylori associated gastritis in the antrum and body of the stomach. Z Gastroenterol 28:229–233

    PubMed  CAS  Google Scholar 

  36. Stolte M, Eidt S, Ritter M, Bethke B (1989) Campylobacter pylori und Gastritis. Pathologe 10:21–26

    PubMed  CAS  Google Scholar 

  37. Gad A, Hradsky M, Furugard K, Malmodin B (1989) Campylobacter pylori and gastroduo-denal ulcer disease. Scand J Gastroenterol 24 [Suppl 167]: 81–85

    Article  Google Scholar 

  38. Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, Sladen GE (1988) Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 29:1386–1391

    Article  PubMed  CAS  Google Scholar 

  39. Drumm B, Sherman P, Chiasson D, Karmali M, Cutz E (1988) Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin. J Pediatr 113:908–912

    Article  PubMed  CAS  Google Scholar 

  40. Dooley CP, McKenna D, Humphreys H, Bourke S, Keane CT, Sweeney E, O’Morain C (1988) Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy. Am J Gastroenterol 83:278–282

    PubMed  CAS  Google Scholar 

  41. Gad A, Hradsky M, Furugard K, Malmodin B, Ny berg O (1989) Campylobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol 24 [Suppl 167]: 44–48

    Article  Google Scholar 

  42. Hirschl AM, Hentschel E, Schütze K, Nemec H, Pötzi R, Gangl A, Weiss W, Pletschette M, Stanek G, Rotter ML (1988) The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 23 [Suppl 142]: 76–81

    Article  Google Scholar 

  43. Cadranel S, Keppens E, Koslowski M, Verhas M, Glupczynski Y, De Prez C (1990) Detection of HP infection in children by means of a standardised 13C-urea-breath test. Rev Esp Enferm Dig 78 [Suppl 1]:A84

    Google Scholar 

  44. Bell GD, Weil J, Harrison G, Morden A, Johnes PH, Gant PW, Trowell JE, Yoong AK, Daneshmed TK, Logan RF (1987) 14C-Urea breath analysis as non-invasive test for Campylobacter pylori in the stomach. Lancet 1:1367–1368

    Article  PubMed  CAS  Google Scholar 

  45. Rauws EAJ, Royen EAV, Langenberg W, Woensel JV, Vrij AA, Tytgat GN (1989) 14C-Urea breath test in Campylobacter pylori gastritis. Gut 30:798–803

    Article  PubMed  CAS  Google Scholar 

  46. Marshall BJ, Surveyor I (1988) Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis. J Nucl Med 29:11–16

    PubMed  CAS  Google Scholar 

  47. Henze E, Malfertheiner P, Clausen M, Glasbrenner B, Lietzenmayer R, Schoetensack C, Burkhardt H, Adam WE (1989) Der C-14 Urea Test-Ein neuer nuklearmedizinischer Test für die Campylobacter-pylori-Diagnostik. Nucl Med 28 : A34

    Google Scholar 

  48. Husebye E, O’Leary D, Skar V, Melby K (1990) How reliable are the 14C-urea breath test and specific serology for the detection of gastric Campylobacter? Scand J Gastroenterol 25:725–730

    Article  PubMed  CAS  Google Scholar 

  49. Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley CR, Wilson WR, DiMagno EP, Zinsmeister AR, Phillips SF (1990) 14C urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sei 35:879–884

    Article  CAS  Google Scholar 

  50. Coelho LGV, Chausson Y, Passos MCF, Sadala RU, Costa EL, Sabino CVS, Queiroz DMM, Mendes EN, Rocha GA, Oliveira CA, Lima GF, Fernandes M LM, Castro LP (1990) Test respiratoire á l’urée marquée au carbone-14 pour le diagnostic de la colonisation gastrique par Helicobacter pylori. Gastroenterol Clin Biol 14:801–805

    PubMed  CAS  Google Scholar 

  51. Bardhan K, Cole DS, Hawkins BW, Franks CR (1982) Does treatment with Cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J 284:621–623

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Georg August University of Göttingen, Robert-Koch-Str. 40, 3400, Göttingen, Germany

    F. E. Bauer, I. Meineke & J. V. Geletneky

  2. Department of Surgery, Georg August University of Göttingen, Robert-Koch-Str. 40, 3400, Göttingen, Germany

    G. Lepsien & F. E. Lüdtke

  3. Department of Pathology, Georg August University of Göttingen, Robert-Koch-Str. 40, 3400, Göttingen, Germany

    A. Schauer

Authors
  1. F. E. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Lepsien
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Meineke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. V. Geletneky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Schauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. E. Lüdtke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hospital de la Princesa, Autonoma University of Madrid, Diego de Leon, 62, 28006, Madrid, Spain

    José M. Pajares M.D., Ph.D. (Professor of Medicine, Head of Department of Gastroenterology) (Professor of Medicine, Head of Department of Gastroenterology)

  2. Free University of Amsterdam, De Boelelaam 1117, 1081 HV, Amsterdam, The Netherlands

    A. Salvador Peña M.D., Ph.D. (Professor of Gastrointestinal Immunology) (Professor of Gastrointestinal Immunology)

  3. Abt. Innere Medizin II, Universitäts Klinik Ulm, Robert-Koch-Str. 8, W-7900, Ulm, Germany

    Peter Malfertheiner Prof. Dr. med.

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bauer, F.E., Lepsien, G., Meineke, I., Geletneky, J.V., Schauer, A., Lüdtke, F.E. (1993). Treatment of Helicobacter pylori-Positive Lesions: 13C-Urea Breath Test Monitoring and Morphology. In: Pajares, J.M., Peña, A.S., Malfertheiner, P. (eds) Helicobacter pylori and Gastroduodenal Pathology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77486-7_57

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77486-7_57

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77488-1

  • Online ISBN: 978-3-642-77486-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation